8 results
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
commonly used diabetic ... #pharmacology #dm2 ... #diabetes #medications ... overview #management #comparison
Summary of Non-Insulin Agents Used to Treat Diabetes

#Diabetes #Pharmacology #Comparison #Table #Medications #Noninsulin #Orals #Agents
of Non-Insulin Agents ... Used to Treat Diabetes ... #Diabetes #Pharmacology ... #Comparison #Table ... Noninsulin #Orals #Agents
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... anti-hyperglycemic agents ... manage Type 2 diabetes ... #pharmacology #pharmacotherapy ... #table #comparison
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... major adverse CV events ... EricsMedicalLectures/featured #diabetes ... medications #table #comparison ... endocrinology #dm2
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... effective oral agent ... #Metformin #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Hypoglycemics in Diabetes ... ) 4 INCRETIN AGENTS ... Hypoglycemics #Diabetes ... #Management #pharmacology ... #DM2 #DMII #Classification
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... insulin in Type 1 Diabetes ... #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
HER2 agents cause ... attributed to HER2 agents ... hypertension, diabetes ... every 4 weeks if agent ... cardiology #oncology #pharmacology